source
- Analysts spot several biotech firms as likely M&A targets amid rising pharma deal activityPharma companies are actively looking for acquisition opportunities, and analysts have identified a handful of biotech firms that could be next in line for buyouts. Recent transactions have center…
- AstraZeneca and BMS deny merger talks, Reuters says no dealReuters reported that rumors of a merger between AstraZeneca and Bristol Myers Squibb have been dismissed. A senior source close to the matter told Reuters there is no deal and no discussions betw…